Pentetate calcium trisodium Pregnancy and Breastfeeding Warnings
Pentetate calcium trisodium is also known as: AN-DTPA
Pentetate calcium trisodium Pregnancy Warnings
Pentetate calcium trisodium has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of teratogenicity based on the removal of zinc which is known to affect DNA and RNA synthesis in humans. There are no controlled data in human pregnancy. Multiple doses of pentetate calcium trisodium could result in an increased risk for adverse reproductive outcomes and thus are not recommend for use during pregnancy, except in cases of high internal radioactive contamination. In these cases, the risk of immediate and delayed radiation-induced toxicity to both the mother and the fetus should be considered in comparison to the risk of pentetate calcium trisodium toxicity. Also, because pentetate calcium trisodium is more effective than pentetate zinc trisodium in the first 24 hours after internal contamination, it may be appropriate to use a single dose of pentetate calcium trisodium with vitamin or mineral supplements that contain zinc as the initial treatment.
Pentetate calcium trisodium Breastfeeding Warnings
Radiocontaminants are known to be excreted in breast milk. Women with known or suspected internal contamination should not breast-feed, whether or not they are receiving chelation therapy. Precautions should be taken when discarding breast milk.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.